Neuropace, Inc. · NASDAQ:NPCE
Morgan Stanley reported a 8.30% stake in Neuropace, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 4, 2025
Morgan Stanley reported a 8.30% stake in Neuropace, Inc., 2,489,391 shares, as a passive investor on Dec 31, 2024. Filed Feb 4, 2025 (Schedule 13G/A).
- Stake
- 8.30%
- Shares
- 2,489,391
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 8.30% | 2,489,391 |
| Morgan Stanley Capital Services LLC | 8.20% | 2,455,896 |